Facial Emotion Recognition in Patients Who Committed Sexual Assault Against Children: an EEG Study

NCT ID: NCT05383235

Last Updated: 2025-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-12

Study Completion Date

2025-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare the emotional processing in sexual offenders against children versus healthy volunteers using an objective electrophysiological measurement (EEG) during a facial emotion stimuli presentation task. Secondary goal is to assess emotion recognition performances in this population and evaluate the impact of various factors on these performances (type of emotion, age and sex of person expressing the emotion, neuropsychological and cognitive abilities of the subjects).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sexual abuse is a major public health issue. Apart from medical care of victims, it appears essential to intervene with sexual offenders for prevention purposes (from primary prevention to avoid a first sexual abuse to secondary and tertiary prevention to avoid recurrence). In order to improve those prevention strategies, further understanding of offenders neuropsychological and cognitive processes is needed.

Facial emotion recognition capacities, that play a major role in social cognition and generation of appropriate social behavior, has been the subject of few studies in sexual offenders. These studies show heterogeneous results and only one of them specifically targets sexual offenders against children. Furthermore, no study has investigated facial emotion recognition in this population with an objective measurement of emotional processing, such as electroencephalographic (EEG) activity. LPP (late positive potential) amplitude, measured in EEG, is a marker of emotional processing and appears to be modified in particular populations (eg. psychopaths) in response to negative visual stimuli compared to positive stimuli.

The investigators aim to determine whether LPP amplitude in response to negative facial expressions is modified in sexual offenders against children compared to healthy volunteers and compared to amplitude in response to positive facial expressions.

Effect of facial emotion characteristics (type of emotion, age and sex of person expressing the emotion) on EEG response will be assessed.

Various neuropsychological and cognitive characteristics (facial emotion recognition, theory of mind, psychopathic traits, childhood trauma, and alexithymia) of patients and controls will also be measured through neuropsychological evaluation and completion of scales and questionnaires, in order to investigate the impact of those factors on facial emotion recognition performances.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Child Sexual Abuse Emotion Recognition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

PATIENTS:

1. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting
2. RUN-IN PERIOD:

* Eligibility criteria will be assessed during the multidisciplinary meeting
* Delivery of the information note
3. STUDY:

* Collection of consent form
* Facial emotion stimuli presentation task with EEG recording and facial emotion recognition task
* Neuropsychological evaluation
* Scales + questionnaires
* Debriefing

CONTROLS:

1. RUN-IN PERIOD phone call:

* Study presentation
* Retrieval of sociodemographic characteristics including age and educational level for matching with patients
* Assessment of eligibility criteria
* Psychiatric assessment with MINI 5.0 evaluation
2. STUDY:

* Delivery of the information note
* Collection of consent form
* Facial emotion stimuli presentation task with EEG recording and facial emotion recognition task
* Neuropsychological evaluation
* Scales + questionnaires
* Debriefing
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors
Apart from investigators in charge of inclusions, outcome assessors will not know to which group the subjects belong.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sexual offenders against children

sexual offenders against children

Group Type EXPERIMENTAL

ROUTINE CARE

Intervention Type OTHER

1\. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting about the patient

Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task

Intervention Type DEVICE

2\. RUN-IN PERIOD :

* Eligibility criteria will be assessed during the multidisciplinary meeting;
* Study presentation, delivery of the information note and consent form; 3. STUDY:
* Collection of consent form;
* Facial emotion stimuli presentation task with EEG recording and facial emotion recording task;
* Neuropsychological evaluation (TOM-15);
* Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE);
* Debriefing.

Healthy controls

Healthy controls

Group Type ACTIVE_COMPARATOR

Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task

Intervention Type DEVICE

2\. RUN-IN PERIOD :

* Eligibility criteria will be assessed during the multidisciplinary meeting;
* Study presentation, delivery of the information note and consent form; 3. STUDY:
* Collection of consent form;
* Facial emotion stimuli presentation task with EEG recording and facial emotion recording task;
* Neuropsychological evaluation (TOM-15);
* Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE);
* Debriefing.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ROUTINE CARE

1\. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting about the patient

Intervention Type OTHER

Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task

2\. RUN-IN PERIOD :

* Eligibility criteria will be assessed during the multidisciplinary meeting;
* Study presentation, delivery of the information note and consent form; 3. STUDY:
* Collection of consent form;
* Facial emotion stimuli presentation task with EEG recording and facial emotion recording task;
* Neuropsychological evaluation (TOM-15);
* Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE);
* Debriefing.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Neuropsychological evaluation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Right-handed ;
* Patient refered to the referral platform for treatment of sexual offenders in Le Vinatier Hospital Center for evaluation of child abuse ;
* Without any Axis 1 disorder ;
* Having given informed consent ;
* Affiliated to French social health care


* Right-handed ;
* Without criminal background ;
* Without any DSM-5 psychiatric disorder (past or present, personal or familial in a first-degree relative) ;
* Non-caregiver employee of Le Vinatier Hospital Center.

Exclusion Criteria

* Intellectual disability (identified during routine care in the referral platform for treatment of sexual offenders);
* Poor understanding of tests and scales instructions ;
* Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
* Gardianship or other tutelage measure

Healthy controls :


* Intellectual disability (using fNART if clinical suspicion during run-in period);
* Poor understanding of tests and scales instructions ;
* Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
* Gardianship or other tutelage measure.
Minimum Eligible Age

25 Years

Maximum Eligible Age

55 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hôpital le Vinatier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sabine MOUCHET, PH

Role: PRINCIPAL_INVESTIGATOR

CH le Vinatier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Le Vinatier

Bron, Auvergne-Rhône-Alpes, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A02763-38

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.